首页> 外文期刊>World Journal of Gastroenterology >Multimodality treatment in hepatocellular carcin- oma patients with tumor thrombi in portal vein
【24h】

Multimodality treatment in hepatocellular carcin- oma patients with tumor thrombi in portal vein

机译:肝细胞癌患者门静脉血栓的多模式治疗

获取原文
获取原文并翻译 | 示例
           

摘要

AIM To compare the therapeutic effect and significances of multimodality treatment for hepatocellular carcinoma (HCC) with tumor thrombi in portal vein (PVTT). METHODS HCC patients (n-1470 with tumor Trombi in the main portal vein or the first brance Of portal vein were divided into four groups by The several therapeutic methods. There were Conservative treatment group in 18 out of Patients (group A); and hepatic artery ligation (HAL) and / or hepatic artery infusion (HAI) group in 18 patients (group B), in whom postoberative chemoembolization was done periodically; group of removal of HCC with PVTT in 79 (group C) and group of transcatheter hepatic arterial chemoembolization (TACE) or HAI and/or portal vein infusion (PVI) after Operation in 32 (group D).
机译:目的比较门静脉肿瘤血栓(PVTT)对肝细胞癌(HCC)多模式治疗的疗效及意义。方法采用几种治疗方法将HCC(门静脉主干或门静脉初发Trombi的n-1470患者)分为四组,其中保守治疗组18例(A组);肝癌定期结扎术后进行化学栓塞的18例患者(B组)进行了动脉结扎(HAL)和/或肝动脉输注(HAI)组; 79例(C组)进行了PVTT切除HCC组(C组)和经导管肝肝动脉组32例手术后进行化学栓塞(TACE)或HAI和/或门静脉输注(PVI)(D组)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号